-+ 0.00%
-+ 0.00%
-+ 0.00%

CONNECT BIOPHARMA - RADEMIKIBART REDUCED TREATMENT FAILURE RATE BY 81% THROUGH ONE MONTH IN PHASE 2 STUDY

Reuters·09/30/2026 11:02:22